Hypoxia in cancer cell metabolism and pH regulation

Essays in Biochemistry

Volumn 43, Issue , 2007, Pages 165-178

  Brahimi Horn, M Christiane ^a   Pouysségur, Jacques ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; UNCLASSIFIED DRUG;

ANIMAL; ANOXIA; BIOLOGICAL MODEL; CELL PROLIFERATION; CYTOPLASM; HUMAN; METABOLISM; MITOCHONDRION; NEOPLASM; PH; PROTEIN PROCESSING; PROTEIN TERTIARY STRUCTURE; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANOXIA; BIOLOGICAL TRANSPORT; CELL PROLIFERATION; CYTOPLASM; GLUCOSE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASMS; OXYGEN; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY;

EID: 35248828654     PISSN: 00711365     EISSN: None     Source Type: Journal    
DOI: 10.1042/BSE0430165     Document Type: Article

References (54)

1. Erecinska, M. & Silver, I.A. (2001) Tissue oxygen tension and brain sensitivity to hypoxia. 128, 263-276
2. Vaupel, P. (2004) Tumor microenvironmental physiology and its implications for radiation oncology. 14, 198-206
3. Manalo, D.J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B.D., Ye, S.Q., Garcia, J.G. & Semenza, G.L (2005) Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-I. 105, 659-669
4. Schofield, C.J. & Ratcliffe, P.J. (2004) Oxygen sensing by HIF hydroxylases. 5, 343-354
5. Semenza, G.L (2003) Targeting HIF-1 for cancer therapy. Not. Rev. Cancer 3, 721-732
6. Ferrara, N. & Kerbel, R.S. (2005) Angiogenesis as a therapeutic target. Nature 438, 967-974
7. Pouysségur, J., Dayan, F. & Mazure, N.M. (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437-443
8. Brahimi-Hom, M.C. & Pouyssegur, J. (2005) The hypoxia-inducible factor and tumor progression along the angiogenic pathway. Int Rev. Cytol. 242, 157-213
9. Maynard, M.A., Qi, H., Chung, J., Lee, E.H., Kondo, Y., Hara, S., Conaway, R.C., Conaway, J.W. & Ohh, M. (2003) Multiple splice variants of the human HIF-3α locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J. Biol. Chem. 278, 11032-11040
10. Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., Cao, Y., Berkenstam, A. & Poellinger, L (2001) Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550-554
11. Jain, S., Maltepe, E., Lu, M.M., Simon, C. & Bradfield, C.A. (1998) Expression of ARNT, ARNT2, HIF 1α, HIF2α and Ah receptor mRNAs in the developing mouse. Mech. Dev. 73, 117-123
12. Bilton, R., Trottier, E., Pouysségur, J. & Brahimi-Horn, M.C. (2006) ARDent about acetylation and deacetylation in hypoxia signalling. Trends Cell Biol. 16, 616-621
13. Brahimi-Horn, C., Mazure, N. & Pouysségur, J. (2005) Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational modifications. Cell. Signalling 17, 1-9
14. Schofield, C.J. & Ratcliffe, P.J. (2005) Signalling hypoxia by HIF hydroxylases. Biochem. Biophp. Res. Commun. 338, 617-626
15. Kaelin, Jr, W.G. (2003) The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. J. Am. Soc. Nephrol. 14, 2703-2711
16. Peet, D. & Linke, S. (2006) Regulation of HIF: asparaginyl hydroxylation. Novartis Found. Symp. 272, 37-49; discussion 49-53, 131-140
17. Dayan, F., Roux, D., Brahimi-Horn, M.C., Pouysségur, J. & Mazure, N.M. (2006) The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1α. Cancer Res. 66, 3688-3698
18. Gruber, M. & Simon, M.C. (2006) Hypoxia-inducible factors, hypoxia, and tumor angiogenesis. Curr. Opin. Hematol. 13, 169-174
19. Gatenby, R.A. & Gillies, R.J. (2004) Why do cancers have high aerobic glycolysis? Nat Rev. Cancer 4, 891-899
20. Lu, H., Dalgard, C.L., Mohyeldin, A., McFate, T., Tait, A.S. & Verma, A. (2005) Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 280, 41928-41939
21. Kaelin, Jr, W.G. (2005) ROS: really involved in oxygen sensing. Cell Metab. 1, 357-358
22. Pouysségur, J. & Mechta-Grigoriou, F. (2006) Redox regulation of the hypoxia-inducible factor. Biol. Chem. 387, 1337-1346
23. Plas, D.R. & Thompson, C.B. (2005) Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24, 7435-7442
24. Schieke, S.M., Phillips, D., McCoy, Jr, J.P., Aponte, A.M., Shen, R.F., Balaban, R.S. & Finkel, T. (2006) The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem 281, 27643-27652
25. Kim, J.W., Tchernyshyov, I., Semenza, G.L. & Dang, C.V. (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2, 177-185
26. Papandreou, I., Cairns, R.A., Fontana, L., Lim, A.L & Denko, N.C. (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3, 187-197
27. Fantin, V.R., St-Pierre, J. & Leder, P. (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9, 425-434
28. 18F]fluorodeoxyglucose positron emission tomography imaging. Clin. Cancer Res. 10, 2245-2252
29. King, A., Selak, M.A. & Gottlieb, E. (2006) Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25, 4675-4682
30. Pollard, P.J., Briere, J.J., Alam, N.A., Barwell, J., Barclay, E., Wortham, N.C., Hunt, T., Mitchell, M., Olpin, S., Moat, S.J. et al. (2005) Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14, 2231-2239
31. Bensaad, K., Tsuruta, A., Selak, M.A., Vidal, M.N., Nakano, K., Bartrons, R., Gottlieb, E. & Vousden, K.H. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107-120
32. Kondoh, H., Lleonart, M.E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A. & Beach, D. (2005) Glycolytic enzymes can modulate cellular life span. Cancer Res. 65, 177-185
33. Matoba, S., Kang, J.G., Patino, W.D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P.J., Bunz, F. & Hwang, P.M. (2006) p53 regulates mitochondrial respiration. Science 312, 1650-1653
34. Blum, R., Jacob-Hirsch, J., Amariglio, N., Rechavi, G. & Kloog, Y. (2005) Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1α, causing gl/colysis shutdown and cell death. Cancer Res. 65, 999-1006
35. Kim, J.W., Zeller, K.I., Wang, Y., Jegga, A.G., Aronow, B.J., O'Donnell, K.A. & Dang, C.V. (2004) Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol. Cell Biol. 24, 5923-5936
36. Levine, A.J., Feng, Z., Mak, T.W., You, H. & Jin, S. (2006) Coordination and communication between the p53 and IGF-1-Akt-TOR signal transduction pathways. Genes Dev. 20, 267-275
37. Shaw, R.J. & Cantley, L.C. (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441, 424-430
38. + exchanger in metastasis. Not. Rev. Cancer 5, 786-795
39. Gerweck, L.E., Vijayappa, S. & Kozin, S. (2006) Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol. Cancer Ther. 5, 1275-1279
40. Ullah, M.S., Davies, A.J. & Halestrap, A.P. (2006) The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-17alpha; dependent mechanism. J. Biol. Chem. 281, 9030-9037
41. Svastova, E., Hulikova, A., Rafajova, M., Zat'ovicova, M., Gibadulinova, A., Casini, A., Cecchi, A., Scozzafava, A., Supuran, C.T., Pastorek, J. & Pastorekova, S. (2004) Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 577, 439-445
42. + exchange activities in renal carcinoma cells. Physiol. Genomics 5, 119-128
43. + exchangers: physiology and link to hypertension and organ ischemia. Curr. Opin. Nephrol. Hypertens. 14, 485-494
44. Shimoda, L.A., Fallon, M., Pisarcik, S., Wang, J. & Semenza, G.L (2006) HIF-1 regulates hypoxic induction of NHEI expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L941-L949
45. Becker, H.M., Hirnet, D., Fecher-Trost, C., Sultemeyer, D. & Deitmer, J.W. (2005) Transport activity of MCT1 expressed in Xenopus oocytes is increased by interaction with carbonic anhydrase. J. Biol. Chem 280, 39882-39889
46. Petrella, B.L., Lohi, J. & Brinckerhoff, C.E. (2005) Identification of membrane type-1 matrix metal-loproteinase as a target of hypoxia-inducible factor-2α in von Hippel-Lindau renal cell carcinoma. Oncogene 24, 1043-1052
47. Gatenby, R.A., Gawlinski, E.T., Gmitro, A.F., Kaylor, B. & Gillies, R.J. (2006) Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 66, 5216-5223
48. Walenta, S. & Mueller-Klieser, W.F. (2004) Lactate: mirror and motor of tumor malignancy. Semin. Radiat Oncol. 14, 267-274
49. Tsutsumi, S., Yanagawa, T., Shimura, T., Kuwano, H. & Raz, A. (2004) Autocrine motility factor signaling enhances pancreatic cancer metastasis. Clin. Cancer Res. 10, 7775-7784
50. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S. & Comoglio, P.M. (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347-361
51. Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E.J. & Krek, W. (2003) Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL Nature 425, 307-311
52. Evans, A.J., Russell, R.C., Roche, O., Burry, T.N., Fish, J.E., Chow, V.W., Kim, W.Y., Saravanan, A., Maynard, M.A., Gervais, M.L. et al. (2006) VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and Snail. Mol. Cell Biol. 27, 157-169
53. Papandreou, I., Krishna, C., Kaper, F., Cai, D., Giaccia, A.J. & Denko, N.C. (2005) Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res. 65, 3171-3178
54. Melillo, G. (2006) Inhibiting hypoxia-inducible factor I for cancer therapy. Mol. Cancer Res. 4, 601-605